Variant report
Variant | nsv972784 |
---|---|
Chromosome Location | chr9:97099816-97103863 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr9:97102032-97102106 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | MYC | chr9:97101986-97102129 | HUVEC | blood vessel: | n/a | n/a |
3 | POLR2A | chr9:97101983-97102142 | HUVEC | blood vessel: | n/a | n/a |
4 | POLR2A | chr9:97101950-97101976 | HUVEC | blood vessel: | n/a | n/a |
5 | REST | chr9:97101057-97101402 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | REST | chr9:97101039-97101341 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | STAT3 | chr9:97102007-97102216 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM22F-2 | chr9:97100629-97101015 | NONHSAT133312 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224815 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182364484 | chr9:97099863-97099864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376184823 | chr9:97099983-97099984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369578786 | chr9:97099991-97099992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs202032838 | chr9:97100011-97100012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547098301 | chr9:97100141-97100142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184463684 | chr9:97100143-97100144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188856564 | chr9:97100152-97100153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548463874 | chr9:97100182-97100183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569960923 | chr9:97100204-97100205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537232580 | chr9:97100228-97100229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2261513 | chr9:97100236-97100237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559074029 | chr9:97100239-97100240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371407474 | chr9:97100366-97100367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577290237 | chr9:97100515-97100516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541653485 | chr9:97100518-97100519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553103508 | chr9:97100553-97100554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112405769 | chr9:97100667-97100668 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs375974342 | chr9:97100679-97100680 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs574769691 | chr9:97100748-97100749 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs181445415 | chr9:97100852-97100853 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs367712912 | chr9:97100899-97100900 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs139393326 | chr9:97100916-97100917 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs149427003 | chr9:97100925-97100926 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
24 | rs116869378 | chr9:97100939-97100940 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
25 | rs376336487 | chr9:97100949-97100950 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs565060881 | chr9:97100957-97100958 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs532109095 | chr9:97100962-97100963 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs545821830 | chr9:97100971-97100972 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs148093106 | chr9:97100977-97100978 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | mRNA abundance |
30 | rs529638490 | chr9:97101091-97101092 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs185534043 | chr9:97101121-97101122 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs2261494 | chr9:97101143-97101144 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs141823710 | chr9:97101144-97101145 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs191263578 | chr9:97101154-97101155 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs537321529 | chr9:97101168-97101169 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs2479568 | chr9:97101169-97101170 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs2261491 | chr9:97101170-97101171 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs146095123 | chr9:97101179-97101180 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs180867966 | chr9:97101181-97101182 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs534848735 | chr9:97101250-97101251 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs368210834 | chr9:97101264-97101265 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs140050311 | chr9:97101284-97101285 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs116705349 | chr9:97101302-97101303 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs186070593 | chr9:97101327-97101328 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs557355317 | chr9:97101464-97101465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536152815 | chr9:97101521-97101522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576424394 | chr9:97101564-97101565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543692864 | chr9:97101569-97101570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529532508 | chr9:97101602-97101603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558481357 | chr9:97101626-97101627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Microcephaly | 18830227 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:97093200-97100800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr9:97095200-97105200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr9:97098000-97109200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr9:97100800-97101000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr9:97101000-97101400 | Enhancers | HUES6 Cell Line | embryonic stem cell |